Last updated 2026-07-27
- Went public on NASDAQ (PLRZ), Oct 2024
- Raised $47.2M Follow-on PO, May 2025
- Raised $2.5M Follow-on PO, Apr 2026
Total raised
$60.4M
Last: PIPE 2026-04
Stage
Public
Founded
2005
Headcount
3
HQ
Ra'anana, Israel
Sector
Health Tech & Life Sciences
About
Polyrizon is a development-stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays. Their proprietary Capture and Contain™ (C&C) hydrogel technology creates a thin shield containment barrier in the nasal cavity to protect against viruses and allergens. They are also developing the Trap & Target™ (T&T) platform for intranasal drug delivery, designed to enhance drug absorption and retention for various pharmaceutical ingredients.
Funding history · 10 rounds · $60.4M total
2026-04
Follow-on PO
$2.5M
2025-12
Follow-on PO
$5.0M
2025-05
Follow-on PO
$47.2M
2024-10
IPO
$4.2M
2023-05
B Round Extension
Undisclosed
★ Xylo Technologies★ srugo Reuven construction co. ltd.
2022-12
B Round
Undisclosed
★ Xylo Technologies★ srugo Reuven construction co. ltd.
2022-04
A Round
$718K
★ Xylo Technologies★ srugo Reuven construction co. ltd.
2021-07
Seed
$780K
★ Xylo Technologies★ srugo Reuven construction co. ltd.
2020-10
Pre-Seed Extension
Undisclosed
★ Xylo Technologies★ srugo Reuven construction co. ltd.
2020-02
Pre-Seed
Undisclosed
★ Xylo Technologies
Headcount over time
From 1 (2019-10) to 7 (2026-01) · +6 (+600%) · 12 points · source: Finder history + radar grounding
Q&A
- When did Polyrizon go public and on what exchange?
- Polyrizon went public on NASDAQ in October 2024 with an Initial Public Offering (IPO) of $4.2 million.
- What is Polyrizon's primary focus as a biotech company?
- Polyrizon is a development-stage biotech company focused on developing innovative medical device hydrogels delivered as nasal sprays, utilizing its proprietary Capture and Contain™ (C&C) and Trap & Target™ (T&T) platforms.
- What was the latest public offering amount for Polyrizon?
- In May 2025, Polyrizon had a public offering of $47.2 million.
- What is the status of Polyrizon's PL-14 Allergy Blocker as of September 2025?
- In September 2025, Polyrizon submitted a Pre-Sub Package to the FDA for its PL-14 Allergy Blocker and reported successful intranasal delivery in its latest study.
- What recent patent expansion did Polyrizon announce?
- In May 2026, Polyrizon announced a U.S. patent expansion for its intranasal drug delivery platform.
- What is the status of Polyrizon's NASARIX™ Allergy Blocker clinical trial as of June 2026?
- In June 2026, Polyrizon secured three U.S. sites for the NASARIX™ trial and received Central IRB approval for its allergy blocker clinical trial.
- What strategic move did Polyrizon announce in March 2026 regarding Colugo?
- In March 2026, Polyrizon announced its intention to acquire up to a 20% stake in Colugo, a developer of advanced eVTOL drones.
Team · 1
Tomer Izraeli
Founder · Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcareProvidersPatientsLife SciencesPharmaceuticals
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
allergybiopharmaceuticalbiotechnologypharmaceuticalsbiomaterialspolymerstopical-treatmentpharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | polyrizon-biotech.com/ |
|---|---|
| linkedin.com/company/202428 |
Identifiers & details
| Legal name | Polyrizon Ltd. |
|---|---|
| Founded | 2005-1 |
| Employees (exact) | 3 |
| Market cap | $8.8M |
| Status reason | Public on NASDAQ on Oct 2024; |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2024-10 | NASDAQ | PLRZ | $4.2M |
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513637025 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 2005-01-12 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 3 — other (1), people (2) |
| Registered address | הפנינה 8 רעננה |
Recent registry events
| Date | Event |
|---|---|
| 2026-01-08 | עדכון כתובת ו/או מען דיגיטלי |
| 2026-05-04 | עדכון בעלי תפקידים |
| 2026-06-02 | עדכון דירקטורים-הוספת דירקטור |